Axcella Health (NASDAQ: [[ticker:AXLA]]) announced it has hired Laurent Chardonnet as its chief financial officer. Chardonnet previously spent 15 years in a variety of finance-related roles at Incyte (NASDAQ: [[ticker:INCY]]), during which time it grew from a clinical-stage outfit to a $20 billion commercial-stage biopharma. Cambridge, MA-based Axcella, which was founded by Flagship Pioneering under the name Pronutria, is developing drugs intended to regulate human metabolism.
Author: Sarah de Crescenzo
Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register.
She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.
View all posts by Sarah de Crescenzo
